Steven Paladino Net Worth

The estimated Net Worth of Steven Paladino is at least 17.3 百万$ dollars as of 25 January 2024. Mr. Paladino owns over 1,620 units of Henry Schein stock worth over 832,627$ and over the last 21 years he sold HSIC stock worth over 13,106,193$. In addition, he makes 3,380,030$ as Chief Financial Officer、 Executive Vice President、 Director at Henry Schein.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Paladino HSIC stock SEC Form 4 insiders trading

Steven has made over 40 trades of the Henry Schein stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 1,620 units of HSIC stock worth 108,621$ on 25 January 2024.

The largest trade he's ever made was exercising 52,000 units of Henry Schein stock on 5 December 2012 worth over 1,845,480$. On average, Steven trades about 5,814 units every 65 days since 2003. As of 25 January 2024 he still owns at least 12,418 units of Henry Schein stock.

You can see the complete history of Mr. Paladino stock trades at the bottom of the page.

Steven Paladino biography

Steven Paladino CPA serves as Chief Financial Officer, Executive Vice President, Director of the Company. He is also a member of our Executive Management Committee. Prior to holding his current position, from 1993 to 2000, Mr. Paladino was Senior Vice President and Chief Financial Officer, from 1990 to 1992, he served as Vice President and Treasurer and, from 1987 to 1990, he served as Corporate Controller. Before joining us, Mr. Paladino was employed as a Certified Public Accountant for seven years, most recently with the international accounting firm of BDO Seidman LLP (now known as BDO USA, LLP). Mr. Paladino brings to the Company’s Board of Directors extensive financial, accounting and industry expertise and a strong, credible reputation within the financial industry. Mr. Paladino’s responsibilities with the Company include the corporate oversight and strategic direction of business units as well as direct responsibility for corporate financial services. These corporate financial services include financial reporting, financial planning, treasury, investor relations, internal audit and taxation. Mr. Paladino also has responsibility for Henry Schein Financial Services (which provides financial business solutions to our customers) and also works with the Corporate Business Development Group on mergers and acquisition activities. Mr. Paladino’s skills in corporate finance and accounting, the depth and breadth of his exposure to complex financial issues and his long-standing relationships with the financial community are valued by the Board of Directors. Mr. Paladino currently serves on the Board of Directors of MSC Industrial Direct Co., Inc. (and is a member of its audit committee and compensation committee).

What is the salary of Steven Paladino?

As the Chief Financial Officer、 Executive Vice President、 Director of Henry Schein, the total compensation of Steven Paladino at Henry Schein is 3,380,030$. There are 2 executives at Henry Schein getting paid more, with Stanley Bergman having the highest compensation of 14,422,900$.

How old is Steven Paladino?

Steven Paladino is 62, he's been the Chief Financial Officer、 Executive Vice President、 Director of Henry Schein since 2000. There are 19 older and 14 younger executives at Henry Schein. The oldest executive at Henry Schein Inc. is Barry Alperin, 79, who is the Independent Director.

What's Steven Paladino's mailing address?

Steven's mailing address filed with the SEC is C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE, NY, 11747.

Insiders trading at Henry Schein

Over the last 22 years, insiders at Henry Schein have traded over 272,732,340$ worth of Henry Schein stock and bought 23,637 units worth 1,414,559$ . The most active insiders traders include Stanley M Bergman、Norman S Matthews、Deborah Derby. On average, Henry Schein executives and independent directors trade stock every 21 days with the average trade being worth of 1,074,342$. The most recent stock trade was executed by Lorelei Mc Glynn on 6 September 2024, trading 21,035 units of HSIC stock currently worth 1,457,726$.

What does Henry Schein do?

henry schein, inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. the company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. a fortune 500® company and a member of the s&p 500® and nasdaq 100® indexes, henry schein employs more than 18,000 team schein members and serves more than one million customers. the company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. henry schein operates through a centralized and automated distribution network, with a selection of more than 100,000 branded products and henry schein private-brand products in stock, as well as more than 150,000 additional products available as special-order items. the company also offers its customers exclusive, innovative technology solutions, including practice

Complete history of Mr. Paladino stock trades at Henry Schein、MSC Industrial Direct Co、Covetrus

Henry Schein executives and stock owners

Henry Schein executives and other stock owners filed with the SEC include:

• Stanley Bergman,
  Chairman of the Board, Chief Executive Officer
• Stanley M. Bergman,
  Exec. Chairman & CEO
• Steven Paladino,
  Chief Financial Officer, Executive Vice President, Director
• Gerald Benjamin,
  Chief Administrative Officer, Executive Vice President, Director
• James Breslawski,
  President, Vice Chairman of the Board, Director
• Mark Mlotek,
  Chief Strategic Officer, Executive Vice President, Director
• James P. Breslawski,
  Exec. Vice Chairman & Pres
• Gerald A. Benjamin,
  Exec. VP, Chief Admin. Officer & Exec. Director
• Steven Paladino,
  Exec. VP, CFO & Exec. Director
• Mark E. Mlotek,
  Exec. VP, Chief Strategic Officer & Exec. Director
• Michael Racioppi,
  Senior Vice President, Chief Merchandising Officer
• Philip Laskawy,
  Lead Independent Director
• Barry Alperin,
  Independent Director
• Joseph Herring,
  Independent Director
• Kurt Kuehn,
  Independent Director
• Bradley Sheares,
  Independent Director
• Carol Raphael,
  Independent Director
• Anne Margulies,
  Independent Director
• Elizabeth Rekow,
  Independent Director
• Shira Goodman,
  Independent Director
• Paul Brons,
  Independent Director
• James Mullins,
  Senior Vice President of Global Services
• Rene Willi,
  President, Global Dental Surgical Group
• David Brous,
  President, Strategic Business Units Group and Asia Pacific & Brazil Dental
• Steven Kess,
  President of the Santa Fe Group
• Carolynne Borders,
  Vice President - Investor Relations
• Jonathan Koch,
  Senior Vice President and Chief Executive Officer, Global Dental Group and Interim Chief Executive Officer, Henry Schein One
• Michael Ettinger,
  Senior Vice President - Corporate and Legal Affairs, Chief of Staff, Secretary
• Lorelei McGlynn,
  Chief Human Resource Officer
• Walter Siegel,
  Senior Vice President, General Counsel
• Christopher Pendergast,
  Senior Vice President, Chief Technology Officer
• Brad Connett,
  President - Henry Schein's U.S. Medical Group
• Olga Timoshkina,
  VP of Corp. Fin., Chief Accounting Officer & Corp. Controller
• Michael Saul Ettinger,
  Exec. VP & COO
• Ronald N. South,
  Sr. VP & CFO
• John Lee,
  VP of Global Compensation & Benefits
• Walter Siegel,
  Chief Legal Officer
• Graham Stanley,
  VP of Investor Relations & Strategic Fin. Project Officer
• Christopher Pendergast,
  Sr. VP & CTO
• Ronald South,
  Chief Accounting Officer & VP of Corp. Fin.
• Paul Rose,
  SVP, Global Supply Chain
• David Mc Kinley,
  President, Medical Group
• Donald J Kabat,
  Director
• Karen Prange,
  EVP&CEO Gl.AH.Med.Den.Sur.Grp
• Lawrence S Bacow,
  Director
• Robert Minowitz,
  President, Int'l Dental Group
• E Dianne Rekow,
  Director
• Peter M. Mc Carthy,
  Pres., Global Animal Health
• Bridget A Ross,
  President, Global Medical Grp
• James A. Harding,
  Chief Technology Officer
• Mohamad Ali,
  
• Deborah Derby,
  
• Michael Zack,
  Senior Vice President
• Larry Gibson,
  Executive V.P. and CTO
• Irving Shafran,
  Director
• Margaret A Hamburg,
  Director
• Marvin Schein,
  
• Pamela Joseph,
  Director
• Stanley Komaroff,
  Senior Advisor
• Lonnie Shoff,
  Pres., Global Healthcare Spec.
• Norman S Matthews,
  Director
• Louis W Sullivan,
  Director
• Karyn Mashima,
  Director
• Leonard A David,
  Vice President
• Reed Vaughn Tuckson,
  
• Scott Philip Serota,
  
• Carole T Faig,
  
• Ronald N. South,
  SVP & Chief Financial Officer